Suchergebnisse - "Tabernero, J"

PubPharm (17)

1

A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial)

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Argilés, G. | Mulet, N. | Valladares-Ayerbes, M. | +58

2

Phase II multicohort study of atezolizumab monotherapy in multiple advanced solid cancers

enthalten in: ESMO open | 2022

von Tabernero, J. | Andre, F. | Blay, J. | +7

3

Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based therapy in metastatic colorectal cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2018

von Siena, S. | Sartore-Bianchi, A. | Garcia-Carbonero, R. | +11

CommentIn: Ann Oncol. 2018 Jan 1;29(1):8-11. - PMID 29087449

4

Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2017

von Grasselli, J. | Elez, E. | Caratù, G. | +20

5

PAN-EX : a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2016

von Sclafani, F. | Brown, G. | Cunningham, D. | +13

6

Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer

enthalten in: British journal of cancer | 2016

von Elez, E. | Hendlisz, A. | Delaunoit, T. | +6

7

Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer : results of the EXPERT-C trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2015

von Sclafani, F. | Chau, I. | Cunningham, D. | +16

8

Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer

enthalten in: British journal of cancer | 2015

von Macarulla, T. | Cervantes, A. | Tabernero, J. | +10

9

Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with KRAS wild-type metastatic colorectal cancer : the randomised phase I/II POSEIDON trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2015

von Élez, E. | Kocáková, I. | Höhler, T. | +14

10

Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer : a randomized phase II study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2015

von Van Cutsem, E. | Boni, C. | Tabernero, J. | +17